Moscow State Academy of Veterinary Medicine and Biotechnology – MVA named after K.I. Scrjabin (Professor)
from 01.01.2020 until now
All-Russian Research Institute of Veterinary Sanitation, Hygiene and Ecology of the Russian Academy of Agricultural Sciences (sotrudnik)
Russian Federation
employee
employee
CSCSTI 68.41
The purpose of the study: to study the bioequivalence of drugs Fluvecto chewable tablets and Bravecto® when administered orally to dogs. Materials and methods: according to the principle of analogues, 2 groups of animals with 6 dogs each were formed. A parallel research design was used for the experiment. The selection of biological material (blood) was carried out before the administration of drugs, and after 2, 4, 8, 24, 30 hours, 2, 3, 4, 7, 14, 21, 28, 35,42, 49, 56, 63, 70, 77 days after administration of the drugs. During the study, concentrations of the active substance of the drugs in the blood plasma of dogs were monitored. The data obtained were used to calculate the pharmacokinetic parameters and assess the bioequivalence of drugs. Results: after oral administration of the drug to dogs, fluralaner is relatively rapidly absorbed into the systemic bloodstream: fluralaner was detected in plasma as early as 2 hours after administration at concentrations of 650-2000 ng/ml, the Tmax index averaged 25 hours for the studied drug, 24 hours for the reference drug. The Cmax was 4,500 ± 1,900 ng/ml for the studied drug and 4,200 ± 2,000 ng/ml for the reference drug. Conclusions: ased on the results obtained, it was concluded that the 90% confidence interval of the ratio of the maximum concentrations of fluralaner of the studied and reference drugs CmaxT/CmaxR is within [80.2; 123.0]. The 90% confidence interval of the ratio of the areas under the pharmacokinetic curves of fluralaner of the studied and reference drugs AUC0-tT/AUC0-tR is within [81.8; 122.8]. Fluvecto chewable tablets and Bravecto® are bioequivalent.
Fluvecto chewable tablets, Bravecto®, fluralaner, bioequivalence, pharmacokinetics, dogs
1. Arisova, G.B. Razrabotka i pervichnye ispytaniya novogo insektoakaricidnogo preparata pri arahnoentomozah sobak / G.B. Arisova, A.V. Loganov, M.V. Arisov // Rossiyskiy parazitologicheskiy zhurnal. ‒ 2011. ‒ №3. – S. 86-89.
2. Vasilevich, F.I. Fauno-ekologicheskie osobennosti parazitirovaniya iksodovyh kleschey Central'noy chasti Vostochno-evropeyskoy ravniny / F.I. Vasilevich, A.M. Nikanorova // Rossiyskiy parazitologicheskiy zhurnal. ‒ 2020. ‒ T. 14. ‒ № 3. ‒ S. 11-17.
3. Gil'dikov, D.I. Klinicheskoe ispytanie perenosimosti i bezopasnosti insektoakaricidnyh preparatov liteyki Dana® Ul'tra (kapli, osheynik, sprey) pri kombinirovannom primenenii u sobak / D.I. Gil'dikov, O.V. Petrova, V.V. Stepanishin // Voprosy normativno-pravovogo regulirovaniya v veterinarii. – 2021. – №. 2. – S. 49-53.
4. Smyslova, P.Yu. Sovremennyy assortiment i mehanizmy deystviya insektoakaricidov dlya melkih domashnih zhivotnyh / P.Yu. Smyslova // Aktual'nye voprosy veterinarnoy biologii. ‒ 2013. ‒ №3 (19). – S. 61-67.
5. Wengenmayer, C. The speed of kill of fluralaner (Bravecto™) against Ixodes ricinus ticks on dogs / S. Wengenmayer, H. Williams, E. Zschiesche, A. Moritz, J. Langenstein, R. Roepke, A. Heckeroth // Parasit. Vectors. - 2014. -V. 7. - P. 525.
6. Rohdich, N. A randomized, blinded, controlled and multi-centered field study comparing the efficacy and safety of Bravecto™ (fluralaner) against Frontline™ (fipronil) in flea- and tick-infested dogs / N. Rohdich, R. K. A. Roepke, E. Zschiesche // Parasit. Vectors. ‒ 2014. ‒ Vol. 7. ‒ pp. 83.
7. Gassel, M. The novel isoxazoline ectoparasiticide fluralaner: selective inhibition of arthropod γ-aminobutyric acid- and L-glutamate-gated chloride channels and insecticidal/acaricidal activity/ M. Gassel, C. Wolf, S. Noack, H. Williams, T. Ilg // Insect. Biochem. Mol. Biol. ‒ 2014. ‒ Vol. 45. ‒ pp. 111-124.
8. Walther, F. The effect of food on the pharmacokinetics of oral fluralaner in dogs/ F. Walther, M. Allan, R. Roepke, M. Nuernberger // Parasites &Vectors. ‒ 2014. ‒ Vol. 7. ‒ Is. 84. ‒ pp. 1-4.
9. Kilp, S. Comparative pharmacokinetics of fluralaner in dogs and cats following single topical or intravenous administration / S. Kilp, D. Ramirez, M. Allan, R. Roepke // Parasites &Vectors. ‒ 2016. ‒ V. 9. ‒ Is. 84. ‒ pp. 1-7.
10. EMEA/V/C/002526/0000 Committee for medicinal products for veterinary use (CVMP). CVMP assessment report for Bravecto. 2014. https://www.ema.europa.eu/en/documents/assessment-report/bravecto-epar-public-assessment-report_en.pdf
11. EMA/CVMP/VICH/463202/2009 VICH topic GL49: Studies to evaluate the metabolism and residues kinetics of veterinary drugs in human food-producing animals: validation of analytical methods used in residue depletion studies. https://www.ema.europa.eu/en/documents/scientific-guideline/vich-gl49-studies-evaluate-metabolism-residue-kinetics-veterinary-drugs-food-producing-animals_en.pdf
12. EMEA. Guideline in bioanalytical method validation. European Medicines Agency. Committee for medicinal products for human use: London (2011).https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf
13. Reshenie Soveta Evraziyskoy ekonomicheskoy komissii ot 21.01.2022 N 1 «O Pravilah regulirovaniya obrascheniya veterinarnyh lekarstvennyh sredstv na tamozhennoy territorii Evraziyskogo ekonomicheskogo soyuza» https://www.alta.ru/tamdoc/22sr0001/?ysclid=lp2ldniqsl799069604
14. Prikaz ot 6 marta 2018 g. №101 Ob utverzhdenii pravil provedeniya doklinicheskogo issledovaniya lekarstvennogo sredstva dlya veterinarnogo primeneniya, klinicheskogo issledovaniya lekarstvennogo preparata dlya veterinarnogo primeneniya, issledovaniya bioekvivalentnosti lekarstvennogo preparata dlya veterinarnogo primeneniya https://www.garant.ru/products/ipo/prime/doc/71802576/?ysclid=lpi26uxscn977807832
15. Federal'nyy zakon ot 12.04.2010 №61-FZ (v red. ot 28.12.2017) «Ob obraschenii lekarstvennyh sredstv». https://www.consultant.ru/document/cons_doc_LAW_99350/?ysclid=lqf1jfvdqw90506968
16. European Convention for the Protection of Vertebrate Animals Used for Experimental and other Scientific Purposes (ETS 123), Strasbourg, 1986 https://rm.coe.int/168007a67b
